The multiple drug resistance gene, MDR1: Expression at the protein and RNA levels Ya Qin LiVenu GopalHarvey Preisler OriginalPaper Pages: 3 - 9
Antibody-directed therapy of multidrug-resistant tumor cells Thomas EfferthManfred Volm OriginalPaper Pages: 11 - 19
Genetic aspects of multidrug resistance Marc PaulyFernand RiesMario Dicato OriginalPaper Pages: 21 - 24
Diverse effect of cytokine treatment of tumor cells on specific versus non-specific cytotoxicity H. NaganumaE. HalapiR. Kiessling OriginalPaper Pages: 25 - 33
Production of prostaglandin e by squamous carcinoma of the head and neck and adenocarcinoma of gastrointestinal tissue F. ČULOI. KlapanB. Bakula OriginalPaper Pages: 35 - 39
Prognostic significance of cytochemical analysis of leukemic M2 blasts Mirna SuČIĆDubravka BobanBoris Labar OriginalPaper Pages: 41 - 45
Leukemic progression as process of adaptation (theoretical model) Igor V. Alekseyev OriginalPaper Pages: 47 - 50
Bone marrow cells in the DNA-synthesis-phase in the myelodysplastic syndrome and lymphome Anne-Marie WenthzelAnja PorwitPeter Reizenstein OriginalPaper Pages: 51 - 55